Category Archives: FDA

Hydroxychloroquine – recent articles

Why do you think our medical monopoly is restricting a simple, inexpensive, effective treatment that works successfully in the rest of the world? Why are European countries, Mexico and Canada especially prone to Covid deaths? Does the degree of restriction on HCQ in a country correlate with the degree of control by Luciferians? Are they trying to kill us? Asking for a friend.

Click for full-size chart

Senators Demand Answers on Hydroxychloroquine from the FDA [August 18, 2020]:
https://aapsonline.org/senators-demand-answers-on-hydroxychloroquine-from-the-fda/
See the full letter from Ron Johnson, Mike Lee and Ted Cruz, here: https://www.hsgac.senate.gov/imo/media/doc/2020-08-18%20RHJ%20Letter%20to%20FDA%20on%20HCQ%20+%20CQ.pdf

AAPS (Association of American Physicians and Surgeons) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine [August 20, 2020]:
https://aapsonline.org/hcqsuit/
See the full complaint here: https://aapsonline.org/judicial/aaps-v-fda-hcq-6-2-2020.pdf

China Recommends Use of Chloroquine Against Covid-19 (China is the first country to recommend the use of chloroquine to treat patients with Covid-19) [August 21, 2020)
https://riotimesonline.com/brazil-news/miscellaneous/covid-19/china-recommends-use-of-chloroquine-against-covid-19/

Dr. David Samadi asked on Twitter: “Can we please put the health of people first and worry about the politics later?” Amen, Doc!

AAPS Physicians Offer Evidence in Support of Hydroxychloroquine

TUCSON – Additional evidence has been submitted to a federal court by the Association of American Physicians & Surgeons as part of its lawsuit the Food & Drug Administration and the Department of Health & Human Services for interfering with the delivery of hydroxychloroquine for treatment of COVID-19.

The group says it filed the lawsuit to “obtain legal redress in support of Trump, by ending the obstruction by the FDA of his policies that would save lives.”

“As confirmed by another recent study of thousands of patients at the Henry Ford Health System in Michigan, HCQ is both very safe and highly effective in treating COVID-19, reducing mortality by 50%,” Association of American Physicians & Surgeons (AAPS) informed the court in its filing. “Countries with underdeveloped health care systems are using HCQ early and attaining far lower mortality than in the United States, where [HHS and the FDA] impede access to HCQ.”

Despite the evidence of efficacy that has accumulated since the COVID-19 pandemic began in Wuhan, China, most Americans are still unable to obtain HCQ for early treatment of COVID-19, and virtually no Americans are able to access it as preventive medicine. HCQ has been used safely for decades by travelers to protect against malaria, but Americans are dying from COVID-19 while HCQ is withheld from them.

“Citizens of the Philippines, Poland, Israel, and Turkey all have greater access to HCQ than American citizens do,” observes AAPS General Counsel Andrew Schlafly. “In Venezuela, HCQ is available over the counter without a prescription, while in the United States pharmacists are prevented from filling prescriptions for HCQ.”

AAPS rebuts arguments presented by the FDA, which implied that medications are approved as safe only for certain conditions. In fact, HCQ and most medications have been approved without limitation, such that physicians can prescribe them for any off-label use.

“The mortality rate from COVID-19 in countries that allow access to HCQ is only one-tenth the mortality rate in countries where there is interference with this medication, such as the United States,” explained Andrew Schlafly. Continue reading AAPS Physicians Offer Evidence in Support of Hydroxychloroquine

The Key to Defeating COVID-19 Already Exists – We Need to Start Using It

By Harvey A. Risch, MD, PhD,
Professor of Epidemiology
Yale School of Public Health
Newsweek, July 23, 2020

As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals. I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines. As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.

I am referring, of course, to the medication hydroxychloroquine. When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.

On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, “Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis.” That article, published in the world’s leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety.

Physicians who have been using these medications in the face of widespread skepticism have been truly heroic. They have done what the science shows is best for their patients, often at great personal risk. I myself know of two doctors who have saved the lives of hundreds of patients with these medications, but are now fighting state medical boards to save their licenses and reputations. The cases against them are completely without scientific merit.

Since publication of my May 27 article, seven more studies have demonstrated similar benefit…

Read more at https://www.newsweek.com/key-defeating-covid-19-already-exists-we-need-start-using-it-opinion-1519535

Fifth Pharmaceutical Company Charged In Ongoing Criminal Antitrust Investigation

Glenmark Pharmaceuticals Inc., USA was charged for conspiring to fix prices for generic drugs, the Department of Justice announced today.

The charge, filed today in the U.S. District Court in Philadelphia, Pennsylvania, alleges that Glenmark conspired with other generic drug companies, including a company with its principal place of business in Montgomery County, Pennsylvania, and Apotex Corp., to increase and maintain prices of pravastatin and other generic drugs beginning in or around May 2013 and continuing until at least in or around December 2015. Pravastatin is a prescription medication that reduces cholesterol, helping to prevent heart attacks and strokes. The charge alleges that the gain to the conspirators, and the loss to the victims, was at least $200 million.

“By cheating through fixing prices, generic drug companies artificially raised prices even though prescription drug costs were already sky high,” said Assistant Attorney General Makan Delrahim of the Department of Justice’s Antitrust Division. “As today’s charge shows, the Antitrust Division will not hesitate to charge these companies, and litigate where necessary, particularly where their crimes resulted in hundreds of millions of dollars in overcharges for life-saving medications.”

“During these difficult times, it is more important than ever that our pharmaceutical companies conduct business with the well-being of the consumer in mind,” said Deputy Special Agent in Charge Steven Stuller, U.S. Postal Service Office of Inspector General. “When generic drug companies conspire to artificially increase prices, they do so to the detriment of many who depend on these medications to maintain good health. Along with the Department of Justice Antitrust Division and our partners at the Federal Bureau of Investigation, the USPS Office of Inspector General will remain committed to investigating those who would engage in this type of harmful conduct.”…

More at https://www.justice.gov/opa/pr/fifth-pharmaceutical-company-charged-ongoing-criminal-antitrust-investigation

The biowarfare/ vaccine origins of many diseases & the OK City bombing – Dr Leonard Horowitz

Who in their right minds would research and create viruses that sicken, maim and kill?

What was the Oklahoma City bombing really about? (32:32)

Fast forward a few decades: Coronavirus Predictive Programming

Here, Dr. Horowitz covers Event 201, which was an exercise for the COVID-19 crisis which began to unfold in real time, only a month later in Wuhan, China. His research and common sense are, as always, impeccable.

COVID fear vs facts – Dr Yvette Lozano from Dallas, Texas

The fear of CV is way out of control. Why are officials, doctors and pharmacies blocking life-saving treatments that work in other countries and are recommended by the President of the USA? Do they hate Trump that much that they will dis him for any reason at all? Do they want CV deaths?

This lady reassures. She is not just an M.D.; she is a healer. CV deaths are unnecessary.

Blood is on the hands of those who block the simple remedies and let people die.

Corruption in Global Health Care May Exceed $1 Trillion

Story at-a-glance

  • Dishonesty and fraud in the health care system, including its academic and research communities, are significant barriers to the implementation of universal health coverage, yet this corruption is rarely if ever discussed, let alone addressed in any meaningful way
  • The less transparent a health system is, the more corrupt it becomes. Weak adherence to the rule of law and few accountability mechanisms further invite corruption and, with it, health system performance, quality and efficiency plummet
  • The amount of corruption found in any given system is dependent on three variables: Monopoly on the supply of a product or service, the level of discretion enjoyed by suppliers, and the supplier’s accountability to others
  • Three factors governing the engagement in corrupt practices in the health care system are: being in a position of power; financial, peer and/or personal pressures; and cultural acceptance of corruption. In order for anticorruption measures to succeed, these three factors all need to be addressed
  • Drug research is beset by an astoundingly high incidence rate of scientific misconduct, with 72% of retracted drug studies being retracted due to things like data falsification, fabrication, unethical conduct and plagiarism

Read the entire article at https://articles.mercola.com/sites/articles/archive/2020/01/08/global-health-care-corruption.aspx

Dr. Ralph Moss on “The Cancer Industry” – The Business of Blood Money

Cancer is big business and knowledge claims on any treatments that earn money and, conversely, on any treatments that do not earn money for the drug companies, are never neutral. Dr Ralph Moss served as the Assistant Director of Public Affairs at America’s most famous cancer research institution, Memorial Sloan Kettering, in Manhattan. He knows the cancer industry inside out. Hear what he has to say and judge for yourself the quality of the evidence against the effectiveness of Vitamin B17: Moss: Short

Source: Dr. Ralph Moss on “The Cancer Industry” – The Business of Blood Money

Pro-GMO Spin Masquerading as Science Courtesy of “Shameful White Men of Privilege”

Devon G. Peña, PhD, an anthropologist at the University of Washington Seattle and an expert in indigenous agriculture, posted a comment to the new campaign’s website in which he called the laureates’ letter “shameful”. He noted that the signatories were:

“…mostly white men of privilege with little background in risk science, few with a background in toxicology studies, and certainly none with knowledge of the indigenous agroecological alternatives. All of you should be stripped of your Nobels.”

Read much more here: Pro-GMO Spin Masquerading as Science Courtesy of “Shameful White Men of Privilege” | Global Research – Centre for Research on Globalization